Surgical Treatment of Sleep Apnea and Snoring
Customize your policy alerts
Sign up for Capital Bluecross Policy MP 1.128 alerts
Get alerted when Policy MP 1.128 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage and medical necessity criteria for surgical and minimally invasive interventions for obstructive and central sleep apnea, including hypoglossal nerve stimulation and palatopharyngoplasty, for members of Capital Bluecross products to which the policy applies.
Phrenic nerve stimulation for central sleep apnea (CSA) has been added to the policy as investigational with associated coding.
Adult hypoglossal nerve stimulation (HNS) criteria were updated to add ≤ 100 AHI and pediatric HNS criteria were modified (lower age limit set to 13 and BMI language changed to percentile-for-age).
Procedure code 41512 has been moved to the non-covered coding table; procedure codes 21299, 31600, 31601, 42870, 42975, and E1399 have been removed from the policy.
Coverage Criteria and Determinations
Palatopharyngoplasty — Adults
Covered when ALL of the following are met
Applies to appropriately selected adults
Hypopharyngeal-targeted surgeries — Adults
Covered when ALL of the following are met
Includes mandibular-maxillary advancement in appropriately selected adults
Adenotonsillectomy — Pediatrics
Covered when ALL of the following are met
Applies to pediatric patients
Hypoglossal nerve stimulation — Adults
Covered when ALL of the following are met
See Policy Guidelines for DISE and collapse assessment
Hypoglossal nerve stimulation — Down syndrome adolescents
Covered when ALL of the following are met
Specific to adolescents/young adults with Down syndrome
Coverage summary and clinical ordering
Coverage stance and clinical sequence summarized from policy text and evidence sections
Surgical Treatments for OSA - Covered
Covered when medically necessary:
See code group for exact mappings
Investigational / Not Covered
Investigational; therefore, not covered:
See coding group for associated codes
Notable coverage updates
Policy-level determinations noted in history entries
Revised coverage criteria highlights
Policy criteria revisions documented in minor reviews (excerpts present in this section); specific full criteria text not included in these chunks.
Updated coverage summaries
Policy updates and coverage stance summaries from this segment
See full policy for complete pre-authorization criteria and contraindications.
See full policy for complete pediatric criteria.
Associated coding added; see coding table.
Recent criteria revisions (partial)
Summary of recent criteria-level changes (document fragment):
From minor review note.
From minor review note.
Added as investigational with associated coding updates.
Updated coverage criteria (high-level)
Policy statements updated (details of the logical criteria are in other parts of the document not included in this excerpt).
Associated coding added; investigational stance applies
See full policy for additional AND/OR criteria
See full policy for BMI percentile thresholds and other criteria
Notable coverage-related updates
Policy revisions and coverage-impacting criteria changes called out in this document segment include:
Investigational designation implies noncoverage per policy rules; full criteria not present in this chunk.
Refer to full policy for remaining inclusion/exclusion criteria.
Refer to full policy for additional pediatric criteria.
Adult HNS criteria (updated)
Policy-level changes referenced in this excerpt (detailed criteria text not present in this section).
Detailed full criteria not included in this excerpt; see other policy sections.
Pediatric HNS criteria (updated)
Full pediatric criteria text not included in this excerpt.
Phrenic nerve stimulation for CSA (investigational)
Associated coding added; investigational = not covered per policy conventions unless specified elsewhere.
Policy changes affecting coverage
Summary of coverage-related changes in this document fragment
Full set of adult HNS criteria not included in this fragment; see full policy for details.
Full pediatric criteria not present in this fragment.
Associated coding was added; full criteria/coverage stance: investigational.
Coverage and investigational statements (updates)
Policy-level coverage and investigational statements (as modified in this update):
Associated coding added; investigational = not covered by policy
Criteria formatting changed to OSA statements
Language aligned to pediatric terminology
Policy change summary (coverage and coding stance)
Summary of coverage stance changes visible in these excerpts:
Added to policy as investigational; associated coding added
Billing with this code may be non-covered
From 08/13/2024 minor review
From 08/13/2024 minor review
HNS — updated coverage criteria
Policy criteria updates for hypoglossal nerve stimulation (HNS)
See full policy for complete eligibility criteria including prior conservative therapy requirements
See full policy for other pediatric eligibility details
Investigational — Phrenic nerve stimulation (CSA)
Phrenic nerve stimulation for central sleep apnea (CSA)
Associated coding added; see coding table
Adult HNS criteria (updated) — 1
Adult hypoglossal nerve stimulation criteria were updated to include an upper AHI limit.
See full policy for complete preexisting criteria
Pediatric HNS criteria (updated) — 1
Pediatric hypoglossal nerve stimulation criteria were revised to set a lower age limit and use BMI percentile language.
See full policy for complete preexisting criteria
Phrenic nerve stimulation for CSA
Phrenic nerve stimulation for central sleep apnea (CSA) was added to the policy and designated investigational.
Claims for this intervention are not considered standard covered therapy per policy
The policy identifies several minimally invasive palatal and tongue procedures as investigational for treatment of obstructive sleep apnea or upper airway resistance syndrome. Examples explicitly listed include laser-assisted palatoplasty (LAUP), radiofrequency volumetric tissue reduction of the palate, radiofrequency volumetric tissue reduction of the tongue, palatal stiffening procedures (e.g., cautery-assisted palatal stiffening, sclerosing injections, palatal implants), tongue base suspension, and other minimally invasive procedures not otherwise described. The policy also states that implantable hypoglossal nerve stimulators are investigational for all indications other than those specifically listed. Finally, interventions listed for treatment of isolated snoring in the absence of documented OSA are considered investigational, since snoring alone is not recognized as a medical condition in this policy.
The policy clarifies that implantable hypoglossal nerve stimulators are considered investigational for all indications except those explicitly listed as covered elsewhere in the policy, citing insufficient evidence to conclude they improve health outcomes when used outside specified indications. Coverage is limited to the device-specific criteria provided in the policy's hypoglossal nerve stimulation sections.
Procedures and devices specifically listed in the policy are designated investigational for treatment of snoring alone. The policy states that snoring without documented obstructive sleep apnea (OSA) is not considered a medical condition and that minimally invasive palatal or tongue procedures for isolated snoring are investigational due to insufficient evidence of benefit.
The policy states that phrenic nerve stimulation for central sleep apnea (CSA) is considered investigational in all situations, indicating that current evidence is insufficient to establish net health benefit and that the therapy is not supported for coverage under the investigational designation.
Within the policy's exclusions and not-medically-necessary statements, certain surgical treatments for OSA and phrenic nerve stimulation for CSA are listed as investigational and therefore not covered. Where a procedure or device is designated investigational in the policy, claims for those services are not supported as medically necessary under the policy language.
The document repeatedly designates phrenic nerve stimulation for central sleep apnea as investigational and not covered. The investigational classification is stated in the policy's not-medically-necessary and exclusions sections and implies noncoverage for related procedures and codes.
Procedure code 41512 has been moved to the policy's non-covered (excluded) coding table. The policy history and coding notes indicate that 41512 is explicitly placed in the non-covered list, and billing with this code should be treated as excluded from coverage per the policy.
The policy history documents coding updates in which procedure code 41512 was moved to the non-covered coding table and several other codes (for example, 21299, 31600, 31601, 42870, 42975, and E1399) were removed from the policy. These code movements and removals reflect explicit operational exclusions or deletions from the policy's covered code sets.
The policy reiterates that use of procedure code 41512 is excluded because it has been moved to the non-covered coding table; the document repeatedly notes this operational coding exclusion in the policy history and coding sections.
The policy places procedure code 41512 in the non-covered coding table, i.e., the code is listed as explicitly excluded from coverage according to the coding placement described in the document.
Policy history and coding notes confirm that procedure code 41512 was moved to the non-covered coding table, representing an explicit exclusion by code in the updated coding tables.
The policy text repeatedly documents that procedure code 41512 is listed in the non-covered coding table, reinforcing that services billed with this code are considered non-covered under the policy excerpts provided.
Multiple segments of the policy confirm the operational coding change: procedure code 41512 is moved to the non-covered coding table. This placement indicates explicit noncoverage when that code is billed.
The policy repeatedly documents that procedure code 41512 has been moved to the non-covered coding table, with accompanying notes in the revision history indicating that 41512 is now an excluded procedure code under this policy fragment.
The document history and coding sections state that procedure code 41512 has been placed in the non-covered coding table; the same update also records that phrenic nerve stimulation for CSA was added as investigational with associated coding changes.
Policy history entries again note that procedure code 41512 is listed in the non-covered coding table, representing an explicit exclusion from coverage when services are billed using this code.
The policy reiterates operational coding changes: procedure code 41512 has been moved to the non-covered coding table, and multiple history entries repeat this exclusion.
As stated in the coding and history sections, procedure code 41512 is listed in the non-covered coding table, an explicit exclusion of that code from coverage under the policy.
The policy groups surgical and device-based interventions that lack sufficient evidence under investigational / not medically necessary language. This includes minimally invasive palatal/tongue procedures, palatal implants, tongue base suspension variations not listed as covered, implantable hypoglossal stimulators outside specified indications, and phrenic nerve stimulation for CSA. Items designated investigational are treated as not medically necessary or not covered in the policy's exclusions and not-medically-necessary sections.
The policy explicitly states that certain procedures and devices are investigational and therefore not covered. That investigational designation applies to specified surgical treatments for OSA in parts of the document and to phrenic nerve stimulation for central sleep apnea, which the policy lists as investigational/not covered.
Some surgical treatments for OSA are designated investigational in parts of the policy; when a procedure is listed as investigational the policy treats that intervention as not medically necessary and not covered.
Multiple policy history entries record that phrenic nerve stimulation for central sleep apnea (CSA) was added to the policy as investigational (INV). The history notes that this investigational designation was accompanied by associated coding updates and appears in the 01/22/2025 minor review and related entries.
Throughout the revision history the policy reiterates that phrenic nerve stimulation for CSA has been added as investigational (INV). The investigational status is documented alongside coding table changes described in the same review notes.
In multiple places the policy restates that phrenic nerve stimulation for central sleep apnea is investigational and therefore not covered; this designation appears in the not-medically-necessary and exclusions language and in the revision history.
The policy text and history entries describe phrenic nerve stimulation for CSA as investigational (INV) and therefore not considered medically necessary or covered under the policy segments provided.
Policy updates and history entries repeatedly note that phrenic nerve stimulation for CSA was added as investigational, with associated coding changes recorded in the document's coding and history sections.
The policy records that phrenic nerve stimulation for central sleep apnea was incorporated into the policy as investigational (INV) and that associated coding updates were included in the revision notes.
Revision history entries emphasize that phrenic nerve stimulation for CSA has been added as investigational. The policy uses this investigational status to indicate that the therapy is not supported as medically necessary under the policy’s current stance.
Policy fragments and history repeatedly identify phrenic nerve stimulation for central sleep apnea as investigational, and that investigational designation is accompanied by coding updates noted in the document.
The policy consistently describes phrenic nerve stimulation for CSA as investigational and not covered across multiple revision notes and coding sections, reflecting the policy’s current noncoverage stance for this therapy.
The document repeatedly restates that phrenic nerve stimulation for central sleep apnea has been added as investigational; investigational interventions are treated as not medically necessary and not covered according to the policy's conventions.
History and coding notes in the policy describe the use of devices or procedures that have been removed from the policy or marked investigational (such as phrenic nerve stimulation for CSA) as likely to be considered not covered or investigational; providers should expect noncoverage for those interventions absent contrary guidance elsewhere in the policy.
Policy revision notes and coding sections document multiple instances where phrenic nerve stimulation for CSA has been listed as investigational, reinforcing the policy’s repeated investigational designation for this therapy.
Coding Tables and Diagnostic Codes
| K982717 | LAUP Radiofrequency ablation (predicate/510k) |
| K040417 | Pillar® Palatal Implant (510k) |
| K122391 | AIRvance® Tongue base suspension (510k) |
| K111179 | Encore™ Tongue base suspension (510k) |
| P130008 | Inspire® Hypoglossal nerve (PMA) |
| S039 | Supplemental/related regulatory code for Inspire |
| No codes listed |
| 21199 | Listed in mapping to specific covered surgical procedure codes |
| 21685 | Mapped from 21199,1 |
| 41120 | Mapped from 21199,2 |
| 41130 | Mapped from 21199,3 |
| 41599 | Mapped from 21199,4 |
| 42145 | Mapped from 21199,5 |
| 42820 | Mapped from 21199,6 |
| 42821 | Mapped from 21199,7 |
| 42825 | Mapped from 21199,8 |
| 42826 | Mapped group with multiple mappings |
| 93151 | Referenced in mapping for phrenic nerve stimulation entries |
| 33277 | Referenced mapping (e.g., 93151, 33277 = 93152) |
| 33278 | Referenced mapping (e.g., 93151, 33278 = 93153) |
| 33281 | Referenced in mapping |
| 33287 | Referenced in mapping |
| 33288 | Referenced in mapping (93151, 33288 = 93150) |
| 93150 | Referenced in mapping |
| C1823 | Referenced in mapping |
| G47.33 | Obstructive sleep apnea (adult) (pediatric) |
| 41512 | Procedure code 41512 (moved to non-covered coding table as noted in policy history) |
| 21299 | Procedure code added to policy coding table (mentioned in history) |
| 31600 | Procedure code added to policy coding table (mentioned in history) |
| 31601 | Procedure code added to policy coding table (mentioned in history) |
| 41120 | Procedure code added to policy coding table (mentioned in history) |
| 41130 | Procedure code added to policy coding table (mentioned in history) |
| 42830 | Procedure code added to policy coding table (mentioned in history) |
| 42831 | Procedure code added to policy coding table (mentioned in history) |
| 42835 | Procedure code added to policy coding table (mentioned in history) |
| 42836 | Procedure code added to policy coding table (mentioned in history) |
| 42870 | Procedure code added to policy coding table (mentioned in history) |
| 41512 | Procedure code 41512 (moved to non-covered coding table) |
| 41512 | Procedure code 41512 moved to non-covered coding table |
| phrenic nerve stimulation (unspecified code) | Phrenic nerve stimulation for CSA added as investigational with associated coding referenced |
| 41512 | Procedure code moved to non-covered coding table |
| 41512 | Procedure code moved to non-covered coding table |
| Phrenic nerve stimulation codes | Associated coding added for phrenic nerve stimulation (CSA) as investigational |
| 41512 | Procedure code moved to non-covered coding table |
| 41512 | Procedure code moved to non-covered coding table |
| 41512 | Procedure code moved to non-covered coding table |
| phrenic nerve stimulation (unspecified code) | Phrenic nerve stimulation for CSA added as investigational with associated coding |
| 41512 | Procedure code moved to non-covered coding table |
| 41512 | Procedure code moved to non-covered coding table (exact descriptor not in chunks) |
| 21299 | Procedure code mentioned as removed from the policy |
| 31600 | Procedure code mentioned as removed from the policy |
| 31601 | Procedure code mentioned as removed from the policy |
| 42870 | Procedure code mentioned as removed from the policy |
| 42975 | Procedure code mentioned as removed from the policy |
| E1399 | Procedure code mentioned as removed from the policy |
| 41120 | Procedure code listed in coding history additions |
| 41130 | Procedure code listed in coding history additions |
| 42830 | Procedure code listed in coding history additions |
| 42831 | Procedure code listed in coding history additions |
| 42835 | Procedure code listed in coding history additions |
| 42836 | Procedure code listed in coding history additions |
| 42950 | Procedure code listed in coding history additions |
| 41512 | Procedure code moved to non-covered coding table |
| 41512 | Procedure code moved to non-covered coding table |
| 21299 | Procedure code referenced (removed from policy) |
| 31600 | Procedure code referenced (removed from policy) |
| 31601 | Procedure code referenced (removed from policy) |
| 42870 | Procedure code referenced (removed from policy) |
| 42975 | Procedure code referenced (removed from policy) |
| E1399 | Miscellaneous HCPCS code referenced (removed from policy) |
| 41120 | Procedure code mentioned as added in document history |
| 41130 | Procedure code mentioned as added in document history |
| 42830 | Procedure code mentioned as added in document history |
| 42831 | Procedure code mentioned as added in document history |
| 42835 | Procedure code mentioned as added in document history |
| 42836 | Procedure code mentioned as added in document history |
Provider Actions, Prior Authorization, and Documentation
Prior authorization required for hypoglossal nerve stimulation
Hypoglossal nerve stimulation (HNS) is covered only when the patient meets the policy’s specific clinical criteria (age, AHI range, CPAP failure or intolerance, BMI limit, and absence of complete concentric collapse); documentation of these criteria is required before authorization.
- Adults: Age ≥18; AHI ≥15 and ≤100 with ≤25% central apneas; CPAP failure or inability to tolerate CPAP; BMI ≤35 kg/m2; absence of complete concentric collapse.
- Down syndrome adolescents: Age 13–18; AHI >10 and <50 with ≤25% central apneas after adenotonsillectomy; ineffective/untolerated CPAP or tracheotomy; BMI ≤95th percentile; absence of complete concentric collapse.
Investigational procedures / codes — phrenic nerve stimulation not covered
Phrenic nerve stimulation and the listed surgical procedure groups are designated investigational and not covered; claims for investigational services are subject to denial and prior authorization will not establish coverage for investigational interventions.
- Phrenic nerve stimulation for central sleep apnea is labeled investigational (INV) and therefore not covered.
- Surgical treatments for OSA listed as investigational may be noncovered; claims using investigational procedure codes may be denied.
Procedure codes and coverage status — PA may be required
Prior authorization may be required for the surgical and implant procedure codes mapped in the policy; covered surgical treatments and their CPT/HCPCS mappings are listed in the coding table and should be used when requesting authorization.
Phrenic nerve stimulation coding/coverage change — added as investigational
Phrenic nerve stimulation for central sleep apnea was added as investigational and associated coding was updated; prior authorization processes should follow the investigational/non-covered coding placement in the policy (authorization does not imply coverage for investigational therapies).
- The policy notes addition of INV designation for phrenic nerve stimulation with associated coding changes.
- Providers should not expect coverage when a procedure is designated investigational in the coding table.
Phrenic nerve stimulation (CSA) investigational — not covered
Phrenic nerve stimulation for CSA is explicitly designated investigational (INV) in the policy and therefore not supported for coverage; prior authorization will reflect investigational status and will not confer coverage.
- Remedē System and other phrenic stimulation systems are described in the policy background, but the therapy is listed as investigational in coding/coverage sections.
- Authorization attempts for investigational CSA phrenic nerve stimulation are unlikely to be approved for payment per policy.
HNS prior authorization updates — include AHI ≤100 and pediatric changes
Prior authorization requirements and clinical criteria for HNS were updated — adult criteria now include an upper AHI limit of ≤100 and pediatric criteria were revised (lower age limit and BMI language); prior authorization review must use the revised criteria.
- Adult HNS: AHI ≥15 and ≤100 (with ≤25% central apneas) — include this threshold in PA documentation.
- Pediatric HNS: lower age limit changed to 13 and BMI criteria expressed as percentile-for-age — reflect these revisions in PA requests.
Coding updates and investigational addition — observe updated coding
Phrenic nerve stimulation for CSA was added as investigational and coding was updated; providers should note the investigational coding additions and confirm code placement before submitting authorization or claims.
- Associated investigational coding entries were added to the policy; reference the coding table when preparing submissions.
- Prior authorization for covered procedures should only use codes listed as covered in the current policy.
Prior authorization — coding changes (moved/removed codes)
Certain procedure codes were moved to the non-covered (excluded) coding table and several codes were removed from the policy; prior authorization and billing must reflect the current coding tables to avoid denial.
HNS adult AHI threshold updated — use AHI ≤100 in PA review
Adult HNS criteria were revised to add an upper AHI threshold of ≤100; prior authorization review and documentation must reflect this updated AHI eligibility limit.
- Include objective sleep study documentation demonstrating AHI within the 15–100 range when requesting authorization for adult HNS.
- If AHI exceeds 100, HNS is outside the updated eligibility per policy.
Phrenic nerve stimulation for CSA marked investigational — PA/claims at risk
Phrenic nerve stimulation for CSA is repeatedly marked investigational in the policy updates; claims and authorization requests for this therapy are at high risk for denial based on investigational status.
- The policy history and coding tables list phrenic nerve stimulation for CSA as INV — investigational designation implies noncoverage.
- Providers seeking authorization for phrenic nerve stimulation should anticipate denials and may need to supply substantive new evidence for reconsideration.
Prior authorization and code coverage changes — phrenic stimulation added as INV; 41512 moved
Phrenic nerve stimulation was added as investigational with associated coding updates and 41512 moved to non-covered; prior authorization expectations should follow the updated coding/coverage designations in the policy.
- Providers should confirm code coverage status before submitting PA requests.
- Investigational designation for phrenic stimulation means PA will not result in standard coverage under this policy.
Prior authorization follows updated coding tables — verify codes
Prior authorization determinations will follow the current coding tables; several codes were moved between covered and non-covered lists or removed from the policy — verify code placement when submitting PAs.
- Claims with removed or non-covered codes may require review or will be denied.
- Use updated coding table in the policy to determine which procedures require PA and which are non-covered.
Prior authorization for HNS — updated adult/pediatric criteria to use in PA
Prior authorization criteria for HNS were revised (adult: added ≤100 AHI; pediatric: age ≥13 and BMI percentile language); PA requests must document compliance with these revised eligibility requirements.
- Include sleep study AHI within updated thresholds and pediatric BMI percentile or age documentation as applicable.
- Document absence of complete concentric collapse (e.g., DISE) where required by policy guidelines.
Prior authorization / code status change — 41512 moved to non-covered
Procedure code 41512 has been moved to the non-covered coding table and related coding expectations updated; prior authorization processes should reflect the non-covered status of 41512.
- Do not expect payment for services billed with CPT 41512 under this policy.
- If using alternative codes for covered procedures, ensure they are listed as covered in the current coding table before authorization.
CPAP first-line before surgery — document prior CPAP/oral appliance trial
Continuous positive airway pressure (CPAP) is the preferred first-line therapy for most patients; surgical options, including HNS, are considered only after an adequate trial of CPAP or an oral appliance has failed or been intolerable.
- Document an adequate trial of CPAP (or oral appliance when appropriate) and evidence of failure/intolerance in any PA request for surgical treatment.
- Policy guidelines explicitly state CPAP is preferred first-line treatment.
Conservative therapy preferred before invasive options — document noninvasive trials
Conservative, noninvasive therapies (e.g., CPAP for hyperventilation-related CSA; supplemental oxygen or bilevel PAP/ASV as appropriate) are preferred before considering invasive procedures; document trials of these therapies prior to PA requests for invasive interventions.
- For CSA, document trials of CPAP and, if indicated, supplemental oxygen or bilevel PAP/ASV per the policy’s therapy sequence.
- The policy notes limited data for phrenic nerve stimulation after failure of standard noninvasive treatments.
Required objective documentation — DISE and sleep study results for surgical/HNS PA
Objective documentation (e.g., DISE demonstrating absence of complete concentric collapse, sleep study results, and evidence of hypopharyngeal obstruction where relevant) is required to support certain surgeries and HNS eligibility and should be included with authorization requests.
- DISE findings must show absence of complete concentric collapse at the soft palate level for HNS candidacy.
- Include polysomnography/REI/AHI reports demonstrating the AHI thresholds required by the policy.
Device regulatory and implantation note — remedē System (PMA P160039)
Device implantation details: the remedē System is FDA-approved (PMA #P160039) for moderate to severe CSA in adults; implantation is performed by a cardiologist with external programming and follow-up — include device and implantation documentation if relevant to requests.
- Remedē System PMA #P160039 is referenced in the policy’s regulatory status section.
- Document the implanting clinician specialty and device programming/follow-up plans when relevant.
Billing note — use appropriate procedure codes (64568 for Inspire V)
Use the policy’s listed procedure codes when billing covered surgical treatments; for hypoglossal stimulation billing, procedure code 64568 may be used to bill the Inspire V Therapy System.
- Reference the covered surgical procedure mapping in the policy coding table when submitting claims and PAs.
- 64568 is noted as usable to bill the Inspire V Therapy System.
Policy history notes — reference prior revisions when documenting PA
Policy history documents prior changes to HNS indications, age and BMI criteria, and coding movements; providers should reference policy history when preparing documentation for authorization or appeals.
- History entries note changes such as addition of ≤100 AHI for adult HNS and pediatric age/BMI language modifications.
- Coding history documents moved and removed codes; review history to understand recent edits.
Suggested documentation to support coverage determination — include revised criteria
When submitting claims or PA requests for HNS or phrenic nerve stimulation, include documentation that the patient meets the revised clinical criteria (age, AHI, BMI or BMI percentile for pediatrics) and any prior authorization required by payer processes.
- For adult HNS include AHI within 15–100 and CPAP failure/intolerance evidence.
- For pediatric HNS include age ≥13 and BMI percentile documentation where applicable; for phrenic nerve stimulation note that the therapy is investigational.
Coding and criteria documentation — use updated code placements
Ensure submitted codes align with the policy’s current coding tables: removed codes (21299, 31600, 31601, 42870, 42975, E1399) should not be used and codes moved to non-covered lists (e.g., 41512) may result in denial.
- Do not submit claims using codes listed as removed from the policy.
- Verify that the procedure code you intend to bill is listed as covered in the most recent policy coding table.
Coding/documentation alignment — reflect current coding table placement
Documentation submitted for authorization should reflect current coding table placement; multiple procedure codes were removed and some moved to non-covered lists — update billing and clinical documentation accordingly.
- Align clinical notes and operative reports with the CPT/HCPCS codes currently listed as covered.
- If previously used codes were removed, select appropriate alternative covered codes per the policy mapping.
Coding update documentation — verify before submission
Ensure submitted codes reflect updated covered/non-covered placement; policy updates reference explicit procedure and CPT/HCPCS code changes — verify coding before PA or claims submission.
- Policy updates removed several codes and moved 41512 to non-covered; adjust claims and PA codes to current policy.
- Coding verification is recommended to avoid denials.
Removed procedure codes — do not use for coverage claims
The policy removed procedure codes 21299, 31600, 31601, 42870, 42975, and E1399; do not use these codes for coverage claims under this policy as they have been deleted from the policy coding sections.
- Claims billed with these removed codes may be denied or not recognized by payer systems.
- Replace removed codes with the correct currently covered code(s) per the policy mapping if applicable.
Documentation note for moved non-covered code — 41512 not covered
Providers should not expect coverage for services billed with code 41512 because the code was moved to the policy’s non-covered coding table; documentation may be required if reconsideration is requested but coverage is not standard.
- CPT 41512 is explicitly listed as non-covered in the policy coding table.
- If submitting for review, include detailed justification and any new evidence but anticipate likely denial based on current policy placement.
Coding updates and documentation — verify coding before submission
Verify coding prior to submission: the policy removed several procedure codes and moved others to non-covered lists; confirmation of code coverage status is recommended before requesting authorization or submitting claims.
- Check the policy coding table for the most recent covered, non-covered, and removed code listings.
- Incorrect coding may lead to claim denial or administrative delay.
Coding verification recommended — check updated tables before billing/PA
Providers should verify coding and coverage prior to submission because the policy revisions include coding table changes and device/service removals that affect authorization and claims.
- Confirm whether a procedure code is covered, moved to non-covered, or removed from the policy before billing.
- Use updated policy guidance when preparing PA requests to reduce risk of denial.
Support for coverage status — provide evidence when challenging investigational designation
Documentation should support whether a requested procedure is classified as covered versus investigational per the updated policy; include evidence (studies, prior therapy trials) if seeking coverage despite an investigational designation.
- For interventions labeled investigational (e.g., phrenic nerve stimulation for CSA), provide clinical justification and new supporting evidence if requesting an exception.
- Coverage determination will follow the policy’s investigational vs covered classification.
Documentation — updated policy sections referenced
Policy sections, background, rationale, and references were updated; providers should reference the updated policy sections for specific documentation requirements and code placements when preparing authorization requests or appeals.
- Refer to the updated Background, Policy Guidelines, Rationale, Coding Table, and References sections for complete requirements.
- Use the policy’s most recent effective/history notes to guide documentation content.
Required documentation for HNS and CSA procedures — reflect updated criteria
Required documentation for HNS and CSA procedures must reflect the revised criteria: adult HNS AHI ≤100; pediatric HNS lower age limit of 13 and BMI percentile-for-age language; note that phrenic nerve stimulation for CSA is listed as investigational.
- Include polysomnography demonstrating AHI within required thresholds and percent central apneas.
- For pediatric HNS include age documentation (≥13) and BMI percentile for age per policy.
Investigational procedures denied — noncompliant procedures at risk for denial
Procedures that do not meet the policy’s medical necessity criteria, including interventions labeled investigational (e.g., minimally invasive palatal/tongue procedures, implantable devices outside listed indications), may be denied as investigational or not medically necessary.
- Minimally invasive palatal or tongue procedures and implantable hypoglossal stimulators outside listed indications are considered investigational.
- Submit objective evidence of meeting medical necessity criteria to avoid denial.
Investigational / Not Covered — denial risk for investigational procedures
Procedures and phrenic nerve stimulation identified as investigational are not covered; claims using procedure codes for investigational treatments may be denied.
- Phrenic nerve stimulation for CSA is designated investigational and therefore not covered under this policy.
- Claims for investigational surgical treatments may be denied; do not anticipate coverage without policy change.
Investigational therapy denial risk — phrenic nerve stimulation (CSA)
Phrenic nerve stimulation for central sleep apnea is designated investigational in the policy; claims for this therapy are likely to be denied based on the investigational classification.
- Remedē System is FDA approved (background), but the policy lists phrenic nerve stimulation as investigational for coverage purposes.
- Authorization requests for phrenic stimulation should note investigational status and anticipate denial.
Investigational surgical treatments — risk of noncoverage
Surgical treatments for OSA that are designated investigational in the policy may be noncovered; verify whether a given surgical procedure is listed as covered or investigational in the policy prior to submitting claims.
- Refer to the policy’s Covered versus Investigational coding tables to determine coverage status for specific surgical procedures.
- Procedures marked investigational should not be billed expecting standard coverage.
Non-covered procedure code — CPT 41512 likely to be denied
Claims using procedure code 41512 may be denied because the code has been moved to the non-covered coding table; do not submit 41512 expecting coverage under this policy.
- Multiple policy entries state CPT 41512 moved to non-covered table — anticipate denial for claims using this code.
- If an alternative covered code exists, submit that code with appropriate documentation instead.
Non-covered procedure code — 41512 denial risk
Claims submitted with procedure code 41512 may be denied because the code was moved to the non-covered coding table; check the policy’s coding placement before billing.
Removed procedure/device codes — claims may be denied
Claims using the removed procedure/device codes (21299, 31600, 31601, 42870, 42975, E1399) may be denied or not recognized by the payer because these codes were explicitly removed from the policy.
- Do not submit claims using these removed codes; they have been deleted from the policy coding sections.
- If a procedure corresponds to a removed code, use the appropriate currently covered CPT/HCPCS code per the policy mapping.
Removed procedure codes — no longer covered
Claims billed with removed codes (21299, 31600, 31601, 42870, 42975, E1399) will no longer be covered under this policy; confirm and use current covered codes to avoid denial.
- These specific procedure codes were removed from the policy and are noted in the policy history and coding tables.
- Billing with removed codes risks denial or non-recognition.
Background and Rationale
The policy background and exclusions emphasize that phrenic nerve stimulation for central sleep apnea is an implantable transvenous stimulation therapy that the policy currently classifies as investigational. As such, the policy treats the therapy as not medically necessary / not covered in the sections where the investigational label is applied.
Definitions and Terms
Policy Revision History
Policy title changed; phrenic nerve stimulation for central sleep apnea (CSA) was added to the policy as investigational with associated coding; procedure code 41512 moved to the non-covered coding table and several procedure codes were removed.
Adult hypoglossal nerve stimulation (HNS) criteria updated to add an upper AHI limit of ≤ 100; pediatric HNS lower age limit changed to 13 and BMI language modified to percentile-for-age.
Hypoglossal nerve stimulation indication changed to AHI ≥15 to align with FDA-approved indication; policy guidelines, references, and coding reviewed.
Phrenic nerve stimulation for central sleep apnea (CSA) was added to the policy as investigational (INV) and associated coding entries were added/updated.
Adult HNS criteria were revised to add an upper Apnea-Hypopnea Index (AHI) threshold of ≤ 100; pediatric HNS criteria updated to change the lower age limit to 13 and to express BMI criteria as percentile-for-age.
Title change implemented and phrenic nerve stimulation for CSA designated investigational (INV) with associated coding added; formatting and criteria statements for OSA were reorganized.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.